Article Information
History
- October 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Gita A. Pathak1,2,
- Robert H. Pietrzak1,2,3,
- AnnMarie Lacobelle1,2,
- Cassie Overstreet1,2,
- Frank R. Wendt1,2,4,
- Joseph D. Deak1,2,
- Eleni Friligkou1,2,
- Yaira Nunez1,2,
- Janitza L. Montalvo-Ortiz1,2,
- Daniel F. Levey1,2,
- Henry R. Kranzler5,
- Joel Gelernter1,2 and
- Renato Polimanti1,2,*
- 1Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- 2U.S Department of Veteran Affairs Connecticut Healthcare System, West Haven, CT, USA
- 3Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA
- 4Regeneron Genetics Center, Regeneron Pharmaceuticals, Tarrytown, NY, USA
- 5Center for Studies of Addiction, University of Pennsylvania Perelman School of Medicine and the Mental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia PA, USA
- ↵*Correspondence
: Renato Polimanti, PhD. Yale University School of Medicine, Department of Psychiatry, 60 Temple, Suite 7A, New Haven, CT 06510, USA. Phone: +1 (203) 737-6391; E-mail: renato.polimanti{at}yale.edu
Posted October 08, 2024.
Epigenetic and Genetic Profiling of Comorbidity Patterns among Substance Dependence Diagnoses
